Drug intelligence / Profile preview

celecoxib + Jintiange

Development stage
Preclinical
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Celecoxib + Jintiange is a combination product consisting of celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), and Jintiange, a traditional Chinese medicine preparation. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces pain and inflammation by blocking the synthesis of prostaglandins involved in these processes[6][7]. It is commonly used for conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and menstrual pain[6][7]. Jintiange refers to an artificial tiger bone powder or capsule formulation used in China as an alternative to natural tiger bone for the treatment of musculoskeletal disorders. It contains calcium phosphate and collagen peptides derived from animal sources (such as bovine or porcine bones) and is believed to support bone health by supplementing minerals and proteins important for bone structure. The combination aims to provide both anti-inflammatory effects from celecoxib and potential bone-strengthening benefits from Jintiange.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on celecoxib + Jintiange.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on celecoxib + Jintiange.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call